U853-char group
Resistance to antineoplastic drugs
⇄ Primary-code rule changed vs QĐ4469
Coding rules (TT06)
- ●Cannot be used as primary diagnosis
Coding guidance (WHO 2019)
Incl.: Non-responsiveness to antineoplastic drugs Refractory cancer
Incl.: Non-responsiveness to antineoplastic drugs Refractory cancer